Skip to main content

Department

Toxicology

Preferred Sample Type

Imipramine and Desipramine

Suitable Specimen Types

  • Serum
  • EDTA Plasma
  • Li Hep Plasma
500 ul of serum/plasma

Specimen Transport

Usual

Sample Processing in Laboratory

Centrifuge and place in toxicology box in cold room.

Sample Preparation

Centrifuge

Turnaround Time

3 working days

Sample Stability

4 ºC

Imipramine and Desipramine

General Information

Imipramine (Tofranil) is the prototype of the tricyclic antidepressant drugs, which now exceed 10 in number and have been among the most frequently used agents for the treatment of depression. They bear a close chemical relationship to the phenothiazines (imipramine is a promazine analogue) and yet have certain distinct pharmacological effects.

Adverse reactions to imipramine therapy include orthostatic hypotension, paresthesias, dry mouth, blurred vision, confusion, disorientation, insomnia, agranulocytosis and paralytic ileus. Fatal hepatic necrosis has been reported. Imipramine toxicity is characterised by hyperactivity, seizures, respiratory depression, hypertension, cardiac arrhythmias, hyperpyrexia, tachycardia, urinary retention, coma, circulatory collapse and death. 

Patient Preparation

For TDM, sample should be taken prior to dose. If toxicity is suspected, take sample at earliest opportunity

Notes

Please avoid use of gel seperator tubes.

Please note this assay is not currently UKAS accredited

Reference Range

Therapeutic concentrations of imipramine range between 50 to 150 ug/L, with the total sum of imipramine and desipramine between 150 and 300 ug/L. 

Specifications

  • EQA Scheme?: Yes
  • EQA Status: LGC QUARTZ, LGC CLIN TOX